Page last updated: 2024-09-04

olmesartan and Oligohydramnios

olmesartan has been researched along with Oligohydramnios in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bou, AJ; Ferreres, AN; Pérez-Iranzo, A1
Friedrich, D; Gortner, L; Herkenrath, P; Hoppe, B; Hünseler, C; Kattner, E; Körber, F; Lindner, U; Müller, A; Oberthuer, A; Paneitz, A; Roth, B; Schaible, T; Schmitt, K; Welzing, L1

Other Studies

2 other study(ies) available for olmesartan and Oligohydramnios

ArticleYear
Maternal olmesartan exposure causing neonatal failure.
    BMJ case reports, 2017, Nov-01, Volume: 2017

    Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Diagnosis, Differential; Female; Humans; Imidazoles; Infant, Newborn; Infant, Premature; Oligohydramnios; Peritoneal Dialysis; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Tetrazoles

2017
Angiotensin II receptor blocker induced fetopathy: 7 cases.
    Klinische Padiatrie, 2011, Volume: 223, Issue:1

    Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Apgar Score; Benzimidazoles; Biphenyl Compounds; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; Hypertension, Pulmonary; Imidazoles; Infant, Newborn; Kidney; Lung; Male; Oligohydramnios; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Renal Insufficiency; Skull; Tetrazoles; Ultrasonography, Prenatal; Valine; Valsartan

2011